-
News | 2021.07.09
The Institut Pasteur International Network is evolving and becoming the Pasteur Network
A new system of governance is being introduced for the Institut Pasteur International Network and its 33 members, which since 2011 have been part of the Pasteur International Network association, which was chaired by the Institut Pasteur President Stewart Cole. Ten years on, the Network is adopting a more participatory, balanced mode of governance and a more structured business model. The...
-
Document de presse | 2021.07.21
SARS-CoV-2 damages ciliated cells and inhibits mucociliary clearance in the airways
COVID-19 is a viral disease with respiratory symptoms that can induce fatal pneumonia. Understanding how SARS-CoV-2 spreads in the respiratory tract can help scientists identify the parameters controlling the severity of infection. Scientists from the Institut Pasteur, the CNRS and Inserm found that SARS-CoV-2 multiplies efficiently in the respiratory tract, and that it primarily targets ciliated...
-
Document de presse | 2021.09.27
SARS-CoV-2: different immune responses observed in nasal mucosa and blood
The clinical manifestations of SARS-CoV-2 infection vary from one individual to the next, and much remains unknown about the mechanisms underpinning this variability. Since the nasal mucosa is one of the first entry points of the virus, scientists from the Institut Pasteur and Inserm, in collaboration with Cochin AP-HP Hospital, analyzed in parallel the immune responses in the nasal mucosa and in...
-
Document de presse | 2021.12.01
Virus related to SARS-CoV-2 found in bats in Cambodia
What are the origins of SARS-CoV-2? This is the world’s most pressing scientific puzzle. Its pieces scattered throughout the world are currently being sought out by scientists. Their goal: to track down the culprit for the largest health crisis to hit the globe in the past century. Scientists at the Institut Pasteur in Paris and the Institut Pasteur du Cambodge have identified a coronavirus in...
-
News | 2021.12.14
2022: the bicentenary of Louis Pasteur's birth
Louis Pasteur was born on December 27, 1822. He was an international figure in scientific and medical research and the founder of the Institut Pasteur (Paris) in 1887. Louis Pasteur was a precursor of a certain way of conducting research, deeply concerned with its goals, both humanistic and universal, and the need to train and transmit this approach and these values to future generations. Today,...
-
News | 2022.01.12
French Prime Minister Jean Castex salutes the Institut Pasteur's expertise on emerging infectious diseases
French Prime Minister Jean Castex, accompanied by Frédérique Vidal, Minister of Higher Education, Research and Innovation, visited the Institut Pasteur on Monday January 10, 2022, to salute the efforts of scientists in the ongoing battle against COVID-19. The visit was an opportunity to highlight the need to strengthen preparedness for future emerging diseases. It was also an auspicious moment...
-
Document de presse | 2022.01.24
Pierre Buffet appointed as Medical Director of the Institut Pasteur
Professor Pierre Buffet has been appointed as Medical Director of the Institut Pasteur. Pierre Buffet took up his post on January 3, 2022 within the Institut Pasteur's Department of Scientific Affairs. Professor Pierre Buffet has been appointed as Medical Director within the Institut Pasteur's Department of Scientific Affairs, led by Senior Executive Scientific Vice-President Christophe d'...
-
Document de presse | 2022.06.07
Institut Pasteur and MSDAVENIR sign a partnership to improve strategies for controlling the spread of vector-borne viral diseases like Zika
The Institut Pasteur and MSDAVENIR, a health research endowment fund by MSD, signed an important partnership to anticipate responses to future vector-borne viral epidemics today. The partnership, worth more than €1.7 million, will support the INTRANZIGEANT project led by Dr. Louis Lambrechts, head of the Virus-Insect Interactions Unit, and Xavier Montagutelli, head of the Mouse Genetics...
-
News | 2022.08.24
ZIKAlliance project: Zika vector competence data reveals risks of outbreaks
A publication published this summer looks back at the contribution of the European ZIKAlliance project, launched in 2016 following the Zika epidemic in the Pacific Islands and America. A global analysis of the competence of potential vectors was carried out, the most comprehensive study of vector competence to date using the same protocols. This study reminds us that vector-borne diseases are...
-
News | 2023.01.30
Hepatitis B: towards better treatment for infected individuals in Africa
With 82 million people currently infected in Africa, the hepatitis B virus represents a major health threat. Early treatment can considerably reduce the risk of complications associated with the disease. In a recent analysis, scientists challenged the suitability of the diagnostic tests used in sub-Saharan Africa and called for more optimized treatment for local populations.